Synthesis and in vitro anti-hepatitis B virus activities of 4-aryl-6-chloroquinolin-2-one and 5-aryl-7-chloro-1,4-benzodiazepine derivatives

被引:113
作者
Cheng, Pi [1 ,2 ]
Zhang, Quan [1 ,2 ]
Ma, Yun-Bao [1 ]
Jiang, Zhi-Yong [1 ]
Zhang, Xue-Mei [1 ]
Zhang, Feng-Xue [3 ]
Chen, Ji-Jun [1 ]
机构
[1] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming 650204, Peoples R China
[2] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China
[3] Guangzhou Univ Tradit Chinese Med, Inst Trop Med Sci, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
4-aryl-6-chloro-quinolin-2-one; 5-aryl-7-chloro-1,4-benzodiazepine; anti-HBV activity;
D O I
10.1016/j.bmcl.2008.05.065
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 4-aryl-6-chloro-quinolin-2-ones and 5-aryl-7-chloro-1,4-benzodiazepine were synthesized and assayed for their in vitro anti-hepatitis B virus activities and cytotoxicities for the first time. Some of the tested compounds were active against HBsAg and HBeAg secretion in Hep G2.2.15 cells. Compound 5c showed IC50 of 0.074 and 0.449 mM on HBsAg and HBeAg secretions, respectively, which were 10 times higher than that of its analog 4c and led to better selective index (SI) values (SI = 23.2 and 3.4, respectively). (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3787 / 3789
页数:3
相关论文
共 33 条
  • [11] QUINAZOLINES AND 1,4-BENZODIAZEPINES .22. A REARRANGEMENT OF 5-PHENYL-1,3-DIHYDRO-2H-1,4-BENZODIAZEPIN-2-ONES
    FRYER, RI
    STERNBACH, LH
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1965, 30 (02) : 524 - +
  • [12] HELENA D, 2007, Patent No. 2007034127
  • [13] The synthesis and structure-activity relationships of 4-aryl-3-aminoquinolin-2-ones: A new class of calcium-dependent, large conductance, potassium (maxi-K) channel openers targeted for post-stroke neuroprotection
    Hewawasam, P
    Fan, WH
    Knipe, J
    Moon, SL
    Boissard, CG
    Gribkoff, VK
    Starrett, JE
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (13) : 1779 - 1783
  • [14] A new triterpene and anti-hepatitis B virus active compounds from Alisma orientalis
    Jiang, Zhi-Yong
    Zhang, Xue-Mei
    Zhang, Feng-Xue
    Liu, Ni
    Zhao, Fang
    Zhou, Jun
    Chen, Ji-Jun
    [J]. PLANTA MEDICA, 2006, 72 (10) : 951 - 954
  • [15] Global control of hepatitis B virus infection
    Kao, JH
    Chen, DS
    [J]. LANCET INFECTIOUS DISEASES, 2002, 2 (07) : 395 - 403
  • [16] 2,5-pyridinedicarboxylic acid derivatives as non-nucleosidic reverse transcriptase inhibitors of hepatitis B virus
    Lee, JS
    Shim, HS
    Park, YK
    Park, SJ
    Shin, JS
    Yang, WY
    Lee, HD
    Park, WJ
    Chung, YH
    Lee, SW
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (19) : 2715 - 2717
  • [17] Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B
    Liaw, YF
    Leung, NWY
    Chang, TT
    Guan, R
    Tai, DI
    Ng, KY
    Chien, RN
    Dent, J
    Roman, L
    Edmundson, S
    Lai, CL
    [J]. GASTROENTEROLOGY, 2000, 119 (01) : 172 - 180
  • [18] Current antiviral therapy for chronic hepatitis B
    Lim, YS
    Suh, DJ
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2004, 19 (04) : 489 - 494
  • [19] Muscia GC, 2006, J CHIL CHEM SOC, V51, P859
  • [20] QUINAZOLINES AND 1,4-BENZODIAZEPINES .62. REACTION OF OXAZIRIDINES WITH WATER OR ALCOHOLS CATALYZED BY IRON SALTS
    NING, RY
    CHEN, WY
    STERNBAC.LH
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1973, 38 (24) : 4206 - 4208